Literature DB >> 16397087

Distal adenomatous polyps are rare in patients with inflammatory bowel disease.

A Dixon1, P Wurm, A Hart, R Robinson.   

Abstract

OBJECTIVE: There is an increased risk of colorectal cancer in patients with inflammatory bowel disease (IBD). The aim of this study was to compare the prevalence of left sided adenomas in patients with IBD aged 55-64 years with a local age matched control population.
METHOD: A review of clinical notes. The prevalence of adenomas in patients with IBD attending for either sigmoidoscopy or colonoscopy was compared with local age matched controls that participated in the national screening trial for colorectal cancer with flexible sigmoidoscopy.
RESULTS: Of 106 patients (61 male, 45 female, mean age of 59 years), 80 suffered from ulcerative colitis, 20 from Crohn's disease, and six from indeterminate colitis. All patients had undergone at least one flexible sigmoidoscopy and 75 had a colonoscopy. Distal adenomas were found in three patients with ulcerative colitis compared with 67 of 749 controls (2.8% v 8.9%, chi(2) = 4.6, p = 0.03).
CONCLUSIONS: The results suggest that distal adenomatous polyps are rare in patients aged 55-64 years with IBD compared with a control population. This supports the hypothesis that lesions other than polyps are important for the development of colorectal cancer in patients with IBD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397087      PMCID: PMC2563726          DOI: 10.1136/pgmj.2005.033779

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  18 in total

1.  Colorectal cancer prevention in ulcerative colitis: a case-control study.

Authors:  J Eaden; K Abrams; A Ekbom; E Jackson; J Mayberry
Journal:  Aliment Pharmacol Ther       Date:  2000-02       Impact factor: 8.171

Review 2.  Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice.

Authors:  David S Fefferman; Richard J Farrell
Journal:  Clin Gastroenterol Hepatol       Date:  2005-01       Impact factor: 11.382

3.  The prognostic value of the modifications of the Dukes' C class of colorectal cancer. An analysis of the NSABP clinical trials.

Authors:  N Wolmark; B Fisher; H S Wieand
Journal:  Ann Surg       Date:  1986-02       Impact factor: 12.969

4.  Intestinal cancer risk and mortality in patients with Crohn's disease.

Authors:  P Munkholm; E Langholz; M Davidsen; V Binder
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

5.  Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study.

Authors:  D Pinczowski; A Ekbom; J Baron; J Yuen; H O Adami
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

6.  Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes.

Authors:  A R Hart; S Kudo; E H Mackay; J F Mayberry; W S Atkin
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

7.  Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire.

Authors:  G A Moody; V Jayanthi; C S Probert; H Mac Kay; J F Mayberry
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-12       Impact factor: 2.566

8.  Adenomatous colonic polyps are rare in ulcerative colitis.

Authors:  T Kitiyakara; D M Bailey; A S McIntyre; D A Gorard
Journal:  Aliment Pharmacol Ther       Date:  2004-04-15       Impact factor: 8.171

9.  Colorectal cancer screening in asymptomatic populations.

Authors:  A R Hart; A C Wicks; J F Mayberry
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

10.  Crohn's disease and cancer: a population-based cohort study.

Authors:  P G Persson; P Karlén; O Bernell; C E Leijonmarck; O Broström; A Ahlbom; G Hellers
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

View more
  5 in total

1.  Prevalence and Anatomic Distribution of Serrated and Adenomatous Lesions in Patients with Inflammatory Bowel Disease.

Authors:  Lik Hang Lee; Marietta Iacucci; Miriam Fort Gasia; Subrata Ghosh; Remo Panaccione; Stefan Urbanski
Journal:  Can J Gastroenterol Hepatol       Date:  2017-01-15

2.  A comparison of epigenetic mitotic-like clocks for cancer risk prediction.

Authors:  Andrew E Teschendorff
Journal:  Genome Med       Date:  2020-06-24       Impact factor: 11.117

3.  Inflammatory polyps occur more frequently in inflammatory bowel disease than other colitis patients.

Authors:  Hassan Ashktorab; Hassan Brim; Sally Hassan; Mehdi Nouraie; Agazi Gebreselassie; Adeyinka O Laiyemo; Angesom Kibreab; Farshad Aduli; Giovanni Latella; Steven R Brant; Zaki Sherif; Aida Habtezion
Journal:  BMC Gastroenterol       Date:  2020-06-05       Impact factor: 3.067

4.  SLC1A1, SLC16A9, and CNTN3 Are Potential Biomarkers for the Occurrence of Colorectal Cancer.

Authors:  Jie Zhou; Zhiman Xie; Ping Cui; Qisi Su; Yu Zhang; Lijia Luo; Zhuoxin Li; Li Ye; Hao Liang; Jiegang Huang
Journal:  Biomed Res Int       Date:  2020-05-23       Impact factor: 3.411

5.  Prevalence and risk factors for colorectal adenomas in patients with ulcerative colitis.

Authors:  Jordi Gordillo; Yamile Zabana; Esther Garcia-Planella; Míriam Mañosa; Jordina Llaó; Ignasi Gich; Laura Marín; Justyna Szafranska; Sergio Sáinz; Xavier Bessa; Eduard Cabré; Eugeni Domènech
Journal:  United European Gastroenterol J       Date:  2017-06-22       Impact factor: 4.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.